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Objectives. The purpose of this study was to quantify the 
severity of transplant coronary artery disease and to assess lesion 
characteristics early and up to 15 years after heart ransplanta- 
tion by using intracoronary ultrasound. 
Background. Intravascular ultrasound has the ability to mea- 
sure the components ofthe arterial wall and has been shown to be 
a sensitive method for detection of transplant coronary artery 
disease. 
Methods. A total of 304 intracoronary ultrasound studies were 
performed in 174 heart ransplant recipients at baseline and up to 
15 (mean 3.3 -+ 0.2) years after transplantation. Mean intimal 
thickness and an intimal index were calculated, and lesion 
characteristics (eccentricity, calcification) were assessed for all 
coronary sites imaged (mean 3.0 + 0.1 sites/study). The Stanford 
classification was used to grade lesion severity. 
Results. Compared with findings in patients tudied at baseline 
(<2 months after transplantation, n = 50), mean intimal thick- 
ness (0.09 + 0.02 vs. 0.16 +- 0.02 ram, p < 0.01), intimal index 
(0.07 -+ 0.01 vs. 0.14 -+ 0.02, p < 0.01) and mean severity class 
(1.5 + 0.2 vs. 2.3 -+ 0.2, p < 0.01) were significantly higher at year 
1 (n = 52) after transplantation. Thereafter, all three variables 
further increased over time and reached highest values between 
years 5 and 15. Calcification of lesions was detected in 2% to 12% 
of studies up to 5 years after transplantation, with a significant 
increase to 24% at years 6 to 10 (p < 0.05). 
Conclusions. Severity of transplant coronary artery disease 
appeared to progress with time after transplantation in this 
cross-sectional study. This characteristic was most prominent 
during the 1st 2 years after transplantation, whereas calcification 
of plaques occurred to a significant extent only later in the 
process. These data may serve as a reference for comparison of 
intravascular ultrasound findings in other studies of patients with 
transplant coronary artery disease. 
(JAm CoU Cardiol 1995;25:171-7) 
Transplant coronary artery disease has emerged as the major 
cause of morbidity and mortality in long-term heart ransplant 
survivors (1-4). The prevalence ofangiographically detectable 
transplant coronary artery disease at 1, 3 and 5 years after 
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transplantation in cyclosporine-treated patients was 14%, 37% 
and 50%, respectively, in the Stanford series (5). However, 
because of the unique morphology of transplant coronary 
artery disease (6), angiography underestimates di ease sever- 
ity, as demonstrated by pathologic-angiographic correlation 
studies (7). Intracoronary ultrasound is a new imaging modal- 
ity that has the ability to image the blood vessels in cross 
section, delineate vessel wall thickness and morphology and 
quantitate lumen dimensions (8-11). The diagnostic value, 
reproducibility and safety of this method in transplant recipi- 
ents have been established by our group (12-14) and by others 
(15,16). Although preliminary reports (17,18) of progression of
transplant coronary artery disease detected with this method 
have appeared, quantitative measurements of transplant cor- 
onary artery disease at various time intervals after transplan- 
tation in a large cohort have not been reported to date. The 
purposes of this study were to quantify the severity of trans- 
plant coronary artery disease and to assess lesion characteris- 
tics to provide a reference for the intraeoronary ultrasound 
appearance of transplant coronary artery disease early and 
during long-term follow-up after heart ransplantation. 
@1995 by the American College of Cardiology 0735-1097/95/$9.50 
0735-1097(94)00323-I 
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Methods  
Study patients. The study group consisted of 174 consecu- 
tive heart transplant recipients (147 men, 27 women with a 
mean age _+ SE at transplantation f 45.2 + 0.7 years) who 
were evaluated with intracoronary ultrasound uring routine 
baseline (early postoperative) or annual coronary angiography. 
Eighty-two of these patients were studied once, 55 twice, 36 
three times and 1 four times at 1- or 2-year intervals. Thus, a 
total of 304 intracoronary ultrasound studies were available for 
analysis, ranging from 2 weeks to 15 years (mean 3.3 _+ 0.2) 
after transplantation. For comparison, patients were catego- 
rized into groups on the basis of the time interval between 
transplantation a d the intracoronary ultrasound study. Sepa- 
rate groups were formed for those who underwent studies 
performed uring the 1st 8 weeks and at 1, 2, 3, 4 and 5 years 
after transplantation. Because of the smaller number of sub- 
jects who underwent intracoronary ultrasound studies long 
after transplantation, those who underwent s udies performed 
between years 6 to 10 and years 11 to 15 after transplantation 
were combined into two additional groups. 
All patients gave written informed consent to the protocol, 
which was approved by the Committee for the Protection of 
Human Subjects in Research at Stanford University Medical 
Center. 
Ultrasound imaging procedure. Intracoronary imaging was 
performed with a 30-MHz ultrasound transducer and rotating 
mirror enclosed within an acoustic housing at the tip of a 5F or 
4.3F 135-cm long catheter (CVIS Inc.). At a focal depth 
between 1.5 and 4.5 ram, axial resolution of the image is 
150 ~m and lateral resolution is 200 ~m. The radius of 
penetration is approximately 5 mm (19). Images were acquired 
at 30 frames/s and recorded on 0.5-in. (1.27-cm) SVHS video- 
tape for subsequent off-line analysis. 
After completion of coronary angiography, sublingual ni- 
troglycerin, 0.4 rag, was given before the intracoronary imaging 
system was passed into the left anterior descending artery over 
a 0.014-in. (0.036 cm) guide wire. An 8F high flow coronary 
guiding catheter with an internal diameter of 0.082 in. 
(0.208 cm) was used for all studies. The ultrasound catheter 
was advanced to the midportion of the left anterior descending 
coronary artery, avoiding vessel segments <2 ram. Up to four 
distinct locations, separated by ->1 cm, were selected for 
ultrasound measurements. Ultrasound gain settings were ad- 
justed for optimal visualization of the vessel-lumen i terface. 
Measurement sites were selected where the lumen was circu- 
lar, and areas of vessel bifurcations and side branches were 
avoided. 
Ultrasound analysis. Ultrasound images were examined 
on-line and later digitized onto a 512 x 512 x 8-bit matrix in 
34 frame sequences by an image processing computer (Dextra 
Medical Inc.) dedicated to echocardiographic analysis. The 
frame at end-diastole with the largest vessel diameter f om the 
digitized cardiac cycle was selected for analysis. The lumen- 
vessel wall interface was traced by planimetry and, if measur- 
able intimal thickness was present, the external border of the 
intimal layer (intima-media nterface) was also measured by 
planimetry. This procedure allowed calculation of mean inti- 
real thickness and an intimal index defined as the ratio of the 
difference of total area minus intimal area to total area. The 
measurements from all sites (mean, 3.0 -+ 0.1 sites/study) were 
averaged for each study. The Stanford classification (12), based 
on intimal thickness and vessel circumference involved, was 
used to grade lesion severity as follows: class 0 = no measur- 
able intimal ayer by ultrasound; class 1 (minimal) = an intimal 
layer <0.3-ram thick involving <180 ° of the vessel circumfer- 
ence; class 2 (mild) = an intimal ayer <0.3 mm thick involving 
>180 ° of the vessel circumference; class 3 (moderate) = an 
intimal ayer 0.3- to 0.5-ram thick or an intimal ayer >0.5-ram 
thick involving <180 °of the vessel circumference; and class 4 
(severe) -- >0.5-ram intimal thickening involving <180 ° of the 
vessel circumference or an intimal layer >1.0 mm at any point 
of the vessel circumference. Patients were classified according 
to the most severe lesion. Intimal thickening >0.3 mm (class 3 
or 4) was considered significant on the basis of reported values 
of intimal thickness in a normal population (20). Eccentric 
lesions were defined as involving <180 ° of the vessel circum- 
ference. Real time images were also reviewed for calcification, 
which was identified by the presence of acoustic shadowing. 
Statistical analysis. Measurements made during succeed- 
ing years on the cohort are averaged for each variable and 
expressed as mean value _+ 1 SEM or percent of patients. The 
differences between means for succeeding years were com- 
puted and the nominal two-sided p value for each comparison 
was calculated. These p values are presented only as an aid to 
the reader. They are conservative because they do not take 
pairing of measurements into account in this cohort study. The 
proportions were handled in a similar fashion. Two sample 
t tests were used for the means and fourfold chi-square t sts for 
the proportions. The tables and graphs indicate pvalues < 0.05 
and < 0.01. 
Results  
Clinical characteristics of the patient groups are listed in 
Table 1. Patients tudied at or >6 years after transplantation 
were significantly ounger at transplantation than patients 
studied at baseline or I to 5 years (p < 0.01). Otherwise, there 
were no significant differences with respect o gender, after 
transplantation diagnosis before transplantation a d number 
of sites studied. Intimal thickness, intimal index and mean 
severity class for the different ime intervals are depicted in 
Table 2 and Figure 1. All three variables were significantly 
higher at year 1 after transplantation than at baseline (intimal 
thickness 0.16 _+ 0.02 mm vs. 0.09 + 0.02 ram, p < 0.01; intimal 
index 0.14 _+ 0.02 vs. 0.07 _+ 0.01, p < 0.01; mean severity class 
2.3 + 0.2 vs. 1.5 _+ 0.2, p < 0.01); intimal thickness was also 
significantly higher at year 2 than at year 1 (0.23 _+ 0.03 mm vs. 
0.16 _+ 0.02 mm, p < 0.05). Thereafter, intimal thickness and 
intimal index continued to increase to a maximum of 0.33 _+ 
0.04 mm at years 5 to 10 and 0.27 _+ 0.05 at years 11 to 15, 
respectively, but differences between successive time intervals 
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Table 1. Clinical Characteristics of the Study Patients 
Age at Pretransplant Diagnosis Sites 
Years After Pts Transplantation Studied 
Transplantation (no.) (yr) Female CMP CAD Other (no.) 
Baseline (<2 mo) 50 49.3 _+ 1.8 6 (12%) 20 (40%) 30 (60%) 0 (0%) 3.3 -+ 0.1 
1 52 48.5 _+ 1.4 12 (23%) 22 (42%) 28 (54%) 2 (4%) 3.0 _+ 0.1 
2 47 45.3 _+ 1.6 7 (15%) 27 (57%) 20 (43%) 0 (0%) 3.0 -+ 0.1 
3 33 47.6 +_ 1.7 6 (18%) 17 (52%) 15 (45%) 1 (3%) 2.9 _+ 0.2 
4 34 46.3 _+ 1.8 7 (21%) 16 (47%) 18 (53%) 0 (0%) 3.2 _+ 0.2 
5 35 43.9 -+ 1.9 7 (20%) 15 (43%) 19 (54%) 1 (3%) 2.8 -+ 0.2 
6 to 10 42 37.7 -+ 1.8' 7 (17%) 16 (38%) 26 (62%) 0 (0%) 3.1 -+ 0.2 
11 to 15 11 32.8 -+ 2.8* 1 (9%) 3 (27%) 7 (64%) 1 (9%) 2.6 -+ 0.3 
*p < 0.01 versus values in groups tudied at baseline and up to year 5 after transplantation. Data are expressed asmean value _+ SEM or number (%) of subjects. 
CAD = coronary artery disease; CMP = cardiomyopathy; Pts = patients. 
were not significant. Mean severity class was highest in studies 
performed at year 5 (3.2 + 0.2). At  baseline, only 11 (22%) of 
50 patients had no evidence of intimal thickening, and intimal 
thickness was classified as mild (class 1 or 2) in another 26 
patients (52%) in this group. The remaining 26% of patients 
with significant lesions in the cardiac graft coronary arteries 
were assumed to have preexisting intimal disease (12). In 
contrast, at 5 years after transplantation, some degree of 
intimal thickening was present in all studies and the percent of 
studies with significant disease (class 3 or 4) increased from 
26% at baseline to 83% at year 5 (Fig. 2). Figure 3 shows the 
prevalence of lesion characteristics in the different groups. 
Eccentric lesions were present in 18% of baseline studies in 
contrast o their presence in 27% to 51% of later studies (p < 
0.01) (Fig. 3A). Calcification of lesions was detected in 2%-  
12% of studies up to year 5 after transplantation a d increased 
significantly to 24% at years 6 to 10 (p < 0.05) and to 46% at 
years 11 to 15 (Fig. 3B). Except for calcification and intimal 
index, transplant coronary artery disease tended to be less 
severe in patients tudied at years 11 to 15 after transplantation 
(intimal thickness 0.30 _ 0.06 mm, intimal index 0.27 +_ 0.05, 
mean severity class 2.8 _+ 0.3 [class 0, 0%; class 3 to 4, 54%] 
and 27% eccentric lesions) than in patients studied at years 
5-10 after transplantation. Intracoronary ultrasound findings 
varied considerably from site to site in each group (Table 3). 
Discuss ion  
This study provides, for the first time, a reference for the 
appearance of transplant coronary artery disease early and 
during long-term follow-up after heart transplantation i  a 
cross-sectional study. The severity of transplant coronary ar- 
tery disease appeared to progress with time, especially during 
the 1st 2 years after transplantation, confirming our previous 
results (21) in a small patient group studied serially with 
intracoronary ultrasound. 
Transplant coronary artery disease is currently the major 
factor limiting long-term survival after heart transplantation 
(22,23), and the pathogenesis of this process remains poorly 
understood. Histologically, the disease is characterized by a 
predominantly diffuse and concentric intimal proliferation in 
large and medium-sized segments of the epicardial coronary 
arteries (24). Also, during the early phases of transplant 
coronary artery disease, intimal hyperplasia is characterized by 
vessel wall expansion with minimal lumen narrowing (25). 
These factors may explain why coronary angiography is usually 
Table 2. Intravascular Ultrasound Variables 
Intimal 
Years After Pts Thickness Intimal Stanford 
Transplantation (no.) (mm) Index Class Ecc Calc 
Baseline (<2 mo) 50 0.09 _+ 0.02* 0.07 -+ 0.01' 1.5 _+ 0.02* 18% 8% 
1 52 0.16 _+ 0.02t 0.14 + 0.02 2.3 - 0.2 44% 2% 
2 47 0.23 -- 0.03 0.17 _+ 0.02 2.5 _+ 0.2 43% 9% 
3 33 0.26 - 0.04 0.20 _+ 0.03 2.7 _+ 0.2 39% 6% 
4 34 0.27 -+ 0.03 0.21 _+ 0.03 2.5 -+ 0.2# 35% 12% 
5 35 0.33 -- 0.04 0.24 + 0.03 3.2 _+ 0.2 51% 6%t 
6 to 10 42 0.33 _+ 0.04 0.25 _+ 0.03 3.0 _+ 0.2 38% 24% 
11 to 15 11 0.30 _+ 0.06 0.27 _+ 0.05 2.8 _+ 0.3 27% 46% 
*p < 0.01, tp < 0.05 versus value in succeeding year. Data are expressed asmean value _+ SEM or percent of studies. 
Calc = studies howing calcification; Ecc = studies howing eccentric lesions; Pts = patients; Stanford Class - Stanford 
classification f lesion severity. 
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Figure 1. Bar graphs showing the correlation of mean intirnal thick- 
ness (A), mean intimal index (B) and mean Stanford class of lesion 
severity (C) with time after transplantation. Data are expressed as 
mean value _+ SEM. BL = baseline (<2 months after transplantation). 
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Figure 2. Bar graph showing the distribution of transplant coronary 
artery disease severity classes 0 to 4 (Stanford classification) in studies 
performed at different time intervals after transplantation. See text for 
definition of classes. BL = baseline (<2 months after transplantation). 
unable to detect the disease until focal stenoses or distal 
pruning of the vessel has developed. The need for improved 
methods for early detection of transplant coronary artery 
disease has prompted the use of intracoronary ultrasound in 
these patients. This technique, incontrast to coronary angiog- 
raphy, allows identification and measurement of the compo- 
nents of the vessel wall, in addition to measurement of lumen 
dimensions. Intracoronary ultrasound has repeatedly been 
shown to be more sensitive than angiography for detecting 
intimal thickening in heart ransplant recipients (12,15,16) and 
is the method of choice to study the early changes of transplant 
coronary artery disease. The choice of 0.3 mm on the intra- 
coronary ultrasound image as the upper limit of normal in the 
present study was derived from prior work by this laboratory 
(19) and from pathologic observations (20) in 216 unselected 
men and women between the ages of 21 and 40 years. The 
range of intimal thickness in the left anterior descending 
coronary artery was 0.066 to 0.301 mm in that population. Only 
22% of our patients tudied during the 1st 2 months after 
transplantation had no evidence of intimal thickening and 26% 
already had class 3 and 4 changes. 
The present data confirm the results of earlier, smaller 
preliminary studies uggesting that prevalence and severity of 
transplant coronary artery disease increase with time after 
transplantation (17,26,27). In the present study, the most 
striking progression of disease occurred uring the 1st 2 years 
after transplantation. This finding is in accordance with a 
previous report from this institution in comparing individual 
coronary sites in a small group of patients tudied serially with 
intracoronary ultrasound (21). After 2 years, progression of 
disease continued from year to year but average intimal 
thickness remained <0.3 mm and severity class remained 0 to 
2 up to 4 years after transplantation. The highest values of 
intimal thickness were measured inpatients 5 to 10 years after 
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Figure 3. Bar graph showing the correlation fpresence ofeccentric 
lesions (A) and calcified lesions (B) with time after transplantation. 
Data are expressed asmean value _+ SEM. BL = baseline (<2 months 
after transplantation). 
transplantation. A tendency to less severe transplant coronary 
artery disease was noted in the subjects tudied later after 
transplantation. This latter group probably represented a 
selection of long-term survivors excluding those patients who 
died earlier from transplant coronary artery disease. However, 
an influence of different imrnunosuppressive regimens used 
over time cannot be excluded because 7 of the 11 patients 
studied 11 to 15 years after transplantation u derwent trans- 
plantation i  the years before cyclosporine was in general use. 
Patients studied 6 to 15 years after transplantation were 
significantly younger than those studied earlier. Whether this 
difference simply reflects increasing upper age criteria for 
recipients over time or points to a better survival in younger 
patients cannot be determined from our data. The only other 
study providing quantitative intracoronary ultrasound ata in 
transplant patients was performed by Anderson et al. (27), who 
reported progression of intimal thickening in a small number 
of patients 1to 8 years after transplantation. 
Although transplant coronary artery disease is considered 
to typically have a diffuse distribution (24), the process is not 
uniform, as highlighted by our findings of considerable varia- 
tion of intimal thickness at different sites in the same vessel and 
the incidence of eccentric lesions present in 35% to 51% of 
studies performed 1 to 10 years after transplantation. Given 
this nonuniformity, it is clear that several vessel segments 
should be studied in the same patient o obtain a sufficient 
sample to assess disease severity. The prevalence of calcified 
lesions was low in the present study during the 1st 5 years after 
transplantation, a finding that has been observed by other 
groups (16,27). However, calcification was significantly more 
frequently visible in patients evaluated later. It can be hypoth- 
esized that calcification is a marker of the age of the allograft 
but is not associated with an adverse prognosis. 
Study limitations. Several limitations of this study have to 
be taken into account when interpreting the results. First, this 
was a cross-sectional r ther than a longitudinal study. The data 
are therefore not valid to assess progression rates of transplant 
coronary artery disease in individual patients. Because intra- 
coronary ultrasound was introduced into clinical use only in 
the late 1980s, results of longitudinal studies in long-term 
survivors will not be available for several years. Second, our 
results represent he incidence and severity of transplant 
coronary artery disease in selected survivors, but not in the 
general heart ransplant population. Patients who died before 
ultrasound follow-up studies of graft atherosclerosis are not 
represented in this study. It is likely that these patients had the 
most severe forms of transplant coronary artery disease and 
that the results obtained here are therefore biased to more 
favorable patterns. As mentioned earlier, this bias is likely to 
explain our finding of less severe transplant coronary artery 
disease in patients tudied 11 to 15 years after transplantation. 
Third, only the proximal two thirds of the left anterior de- 
scending vessel were examined in this study; therefore, the 
reported measurements reflect the disease process in only a 
limited number of coronary sites in each patient. Fourth, the 
study was not performed in blinded manner; the investigators 
had access to clinical information, especially to interval after 
transplantation. However, each intracoronary ultrasound study 
was analyzed separately without knowledge of findings from 
previous studies; therefore, measurement bias is unlikely. 
Fifth, we did not compare intracoronary ultrasound findings 
with coronary angiographic findings. This comparison was not 
the purpose of the present study and the time course of 
angiographic findings after transplantation has been described 
previously (3-5). Finally, we did not correlate clinical and 
laboratory variables with intracoronary ultrasound findings as 
this is a large topic by itself. 
Conclusions. Severity of transplant coronary artery disease 
appeared to progress with time after transplantation, especially 
during the 1st 2 years after transplantation, whereas calcifica- 
tion of plaques occurred to a significant extent only later. 
These observations parallel those of pathologic studies in the 
time course of the disease. We believe that the intracoronary 
ultrasound measurements reported here provide reference for 
future studies. Quantitative measurements of transplant coro- 
nary artery disease obtained with intravascular ultrasound may 
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Table 3. Compar ison of Intravascular  U l t rasound Findings at Different Sites in the Left Anter ior  Descending Coronary Artery 
Years After Average at 
Transplantation All Sites Site 1 Site 2 Site 3 Site 4 
Intimal Thickness (ram) 
Baseline (<2 mo) 0.09 _+ 0.02 0.09 ± 0.02 0.09 _+ 0.02 0.08 + 0.02 0.07 4- 0.02 
1 0.16 _+ 0.02 0.16 + 0.03 0.18 -+ 0.02 0.15 _+ 0.02 0.10 ± 0.02 
2 0.23 _+ 0.03 0.21 _+ 0.03 0.29 ± 0.04 0.23 _+ 0.04 0.13 ± 0.03 
3 0.26 + 0.04 0.24 _+ 0.04 0.32 _+ 0.05 0.33 ± 0.07 0.21 -+ 0.06 
4 0.27 _+ 0.03 0.27 + 0.04 0.25 _+ 0.04 0.32 -+ 0.06 0.21 ± 0.04 
5 0.33 _+ 0.04 0.31 _+ 0.05 0.37 -+ 0.05 0.31 + 0.06 0.28 - 0.06 
6 to 10 0.33 - 0.04 0.28 ± 0.04 0.3l + 0.04 0.39 -+ 0.05 0.30 -+ 0.06 
11 to 15 0.30 + 0.06 0.31 - 0.07 0.31 _+ 0.10 0.27 -+ 0.06 0.22 -+ 0.14 
lntimal Index 
Baseline (<2 mo) 0.07 + 0.01 0.08 -+ 0.01 0.07 _+ 0.0l 0.07 + 0.02 0.06 - 0.02 
1 0.14 - 0.02 0.13 -+ 0.02 0.15 + 0.02 0.13 -+ 0.02 0.10 ± 0.02 
2 0.17 -+ 0.02 0.15 + 0.02 0.22 ± 0.03 0.18 -+ 0.03 0.10 ± 0.03 
3 0.20 _+ 0.03 0.19 -+ 0.03 0.24 -+ 0.03 0.25 + 0.04 0.17 ± 0.05 
4 0.21 + 0.03 0.21 _+ 0.03 0.19 + 0.03 0.24 ± 0.03 0.18 + 0.03 
5 0.24 + 0.03 0.23 -+ 0.03 0.27 -+ 0.03 0.23 + 0.03 0.21 -- 0.03 
6 to 10 0.25 -+ 0.03 0.21 "4- 0.03 0.24 + 0.03 0.29 ± 0.03 0.23 + 0.04 
11 to 15 0.27 -- 0.05 0.28 ± 0.06 0.25 + 0.07 0.24 _+ 0.05 0.20 ± 0.12 
Stanford Classification of Lesion Severity 
Baseline (<2 mo) 1.5 _+ 0.02 1.1 - 0.2 1.1 + 0.2 1.0 - 0.2 1.0 + 0.2 
1 2.3 _+ 0.2 1.8 _+ 0.2 1.9 -- 0.2 1.8 + 0.2 1.5 ± 0.3 
2 2.5 _+ 0.2 2.0 _+ 0.2 2.4 --. 0.2 2.2 _+ 0.2 1.7 ± 0.3 
3 2.7 _+ 0.2 2.3 _+ 0.2 2.6 _+ 0.2 2.7 ± 0.3 2.0 ± 0.3 
4 2.5 +_ 0.2 2.2 _+ 0.3 2.0 ± 0.3 2.3 __ 0.3 2.0 +_ 0.3 
5 3.2 + 0.2 2.7 --- 0.2 2.5 _+ 0.3 2.4 + 0.3 2.4 _+ 0.3 
6 to 10 3.0 _+ 0.2 2.7 + 0.2 2.6 + 0.2 2.8 -- 0.3 2.4 ± 0.4 
11 to 15 2.8 _+ 0.3 2.6 _+ 0.6 2.3 ± 0.4 2.7 ± 0.3 2.3 _+ 0.9 
Eccentric Lesions 
Baseline (<2 mo) 18% 4% 10% 16% 12% 
1 44% 30% 25% 30% 17% 
2 43% 18% 31% 30% 28% 
3 39% 28% 25% 9% 12% 
4 35% 27% 21% 19% 14% 
5 51% 22% 32% 27% 32% 
6 to 10 38% 27% 19% 9% 14% 
11 to 15 27% 11% 0% 22% 0% 
Calcified Lesions 
Baseline (<2 mo) 8% 2% 4% 2% 0% 
1 2% 2% 2% 3% 0% 
2 9% 5% 8% 5% 8% 
3 6% 0% 7% 0% 0% 
4 12% 3% 4% 4% 5% 
5 6% 4% 0% 4% 0% 
6 to 10 24% 12% 8% 18% 5% 
11 to 15 46% 22% 25% 33% 33% 
Data are expressed as mean value _+ SEM or percent of lesions. Boldface values indicate highest and lowest measurements at different sites in the respective time 
interval. 
be useful to assess the impact of prevention and intervention 
strategies, especially early after transplantation. 
We thank Byron Win. Brown, Jr., PhD, Division of Biostatistics, Stanford 
University, for expert assistance with the statistical nalysis. 
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